verapamil has been researched along with Canine Diseases in 9 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The failure of the maximum tolerated dosage to improve seizure control in dogs with phenobarbital-resistant epilepsy argues against the suitability of verapamil add-on treatment to overcome pharmacoresistance." | 7.77 | Add-on treatment with verapamil in pharmacoresistant canine epilepsy. ( Jambroszyk, M; Potschka, H; Tipold, A, 2011) |
| "Intravenous administration of verapamil at low dosage was effective in reversal of atrial tachycardia of unknown origin in a dog." | 7.67 | Reversal of atrial tachycardia with intravenous administration of verapamil in a dog. ( Foodman, MS; Macintire, D, 1989) |
| "The failure of the maximum tolerated dosage to improve seizure control in dogs with phenobarbital-resistant epilepsy argues against the suitability of verapamil add-on treatment to overcome pharmacoresistance." | 3.77 | Add-on treatment with verapamil in pharmacoresistant canine epilepsy. ( Jambroszyk, M; Potschka, H; Tipold, A, 2011) |
| "Intravenous administration of verapamil at low dosage was effective in reversal of atrial tachycardia of unknown origin in a dog." | 3.67 | Reversal of atrial tachycardia with intravenous administration of verapamil in a dog. ( Foodman, MS; Macintire, D, 1989) |
| "Verapamil pretreatment resulted in values of the ATP/ADP ratio which were lower than, but not significantly different from, those observed in the control group." | 1.29 | Protective effect of verapamil on regional myocardial ischaemic injury in dog. ( Kobusiewicz, W; Ledwozyw, A; Michalak, J; Ogonowska-Kobusiewicz, M; Zywicki, W, 1995) |
| "Verapamil was an effective treatment for acutely converting supraventricular tachycardia to sinus rhythm in these dogs." | 1.27 | Verapamil administration for acute termination of supraventricular tachycardia in dogs. ( Keene, B; Kittleson, M; Pion, P; Woodfield, J, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, RN | 1 |
| Levenhagen, MA | 1 |
| Levenhagen, MM | 1 |
| Rieck, SE | 1 |
| Labruna, MB | 1 |
| Beletti, ME | 1 |
| Król, M | 1 |
| Pawłowski, KM | 1 |
| Majchrzak, K | 1 |
| Mucha, J | 1 |
| Motyl, T | 1 |
| Russell, NJ | 1 |
| Irwin, PJ | 1 |
| Hopper, BJ | 1 |
| Olivry, T | 1 |
| Nicholls, PK | 1 |
| Jambroszyk, M | 1 |
| Tipold, A | 1 |
| Potschka, H | 1 |
| Nakaichi, M | 1 |
| Takeshita, Y | 1 |
| Okuda, M | 1 |
| Nakamoto, Y | 1 |
| Itamoto, K | 1 |
| Une, S | 1 |
| Sasaki, N | 1 |
| Kadosawa, T | 1 |
| Takahashi, T | 1 |
| Taura, Y | 1 |
| Kobusiewicz, W | 2 |
| Ogonowska-Kobusiewicz, M | 2 |
| Michalak, J | 2 |
| Zywicki, W | 1 |
| Ledwozyw, A | 2 |
| Foodman, MS | 1 |
| Macintire, D | 1 |
| Kittleson, M | 1 |
| Keene, B | 1 |
| Pion, P | 1 |
| Woodfield, J | 1 |
9 other studies available for verapamil and Canine Diseases
| Article | Year |
|---|---|
The spreading process of Ehrlichia canis in macrophages is dependent on actin cytoskeleton, calcium and iron influx and lysosomal evasion.
Topics: Actin Cytoskeleton; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytochalasins; Defe | 2014 |
Canine mammary carcinoma cell line are resistant to chemosensitizers: verapamil and cyclosporin A.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell | 2014 |
Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Furosemide; | 2008 |
Add-on treatment with verapamil in pharmacoresistant canine epilepsy.
Topics: Age of Onset; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blo | 2011 |
Expression of the MDR1 gene and P-glycoprotein in canine mast cell tumor cell lines.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumo | 2007 |
Protective effect of verapamil on regional myocardial ischaemic injury in dog.
Topics: Animals; Calcium Channel Blockers; Cell Membrane; Dog Diseases; Dogs; Fatty Acids, Nonesterified; He | 1995 |
The influence of nifedipine and verapamil on the ischaemia-induced changes in canine sarcolemmal membranes.
Topics: Animals; Calcium Channel Blockers; Calcium-Transporting ATPases; Cell Membrane; Dog Diseases; Dogs; | 1995 |
Reversal of atrial tachycardia with intravenous administration of verapamil in a dog.
Topics: Animals; Dog Diseases; Dogs; Electrocardiography; Heart Atria; Male; Tachycardia; Verapamil | 1989 |
Verapamil administration for acute termination of supraventricular tachycardia in dogs.
Topics: Animals; Dog Diseases; Dogs; Electrocardiography; Heart Rate; Prospective Studies; Tachycardia, Supr | 1988 |